TheJobsMapTransCode Therapeutics, Inc. jobs and careers
Waltham, MA, United States
About TransCode Therapeutics, Inc.
TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. Our lead therapeutic candidate, that we believe has blockbuster potential, targets an RNA molecule which has been shown to be the driver of metastatic disease across multiple tumor typesand has been validated pre-clinically in our lab at MGH. Our initial FIH clinical study, for which an eIND filing is planned for Q1 of 2022, is intended to provide positive proof-of-mechanism for the TTX platform.
Founded in 2016 by R. Michael Dudley and Zdravka Medarova.
- Founded
- 2016
- Employees
- 11 to 50
- Total funding
- $28.1M
- Headquarters
- Waltham
Leadership
The top of TransCode Therapeutics, Inc.'s org chart, with how many people report into each leader.
Sue Duggan,RN MBA
Senior Vice President, Operations
3 reports
Tom Fitzgerald
Chief Financial Officer; Director
1 report
Subrata Ghosh, MS, PhD.
Principal Scientist
Zdravka Medarova
Chief Technology Officer
Neil Robertson
Senior Scientist
Benjamin D'Alessio
Director, CMC
Tania Montgomery
Director of Business Development/ Strategic Marketing
Lisa Fortin
Director Clinical Operations
Joann Brown
Staff Accountant
Jobs at TransCode Therapeutics, Inc.
No open positions right now. Explore more companies on TheJobsMap.